SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors aggressively debate the upcoming announcement of the trial's 80th event, with bullish community members highlighting potential acquisition interest from major pharmaceutical companies while bears express skepticism regarding trial integrity and dilution risks. The conversation is heavily focused on the high short interest and the anticipation that positive topline results could trigger a significant market move.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant community attention as investors position for imminent Phase 3 clinical data, with many speculating that positive results will drive a material rerating or M&A activity. The community is heavily focused on the potential for the VELA-52 week readout to confirm a best-in-disease profile, while also monitoring strategic updates and potential acquisition interest from major pharmaceutical players.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML remains a central focus for semiconductor investors as it balances robust AI-driven demand and raised FY26 guidance against market scrutiny regarding high-NA EUV adoption timelines and geopolitical export restrictions. The community is actively debating the company's long-term monopolistic moat versus near-term valuation sensitivity, while monitoring heavy institutional flow that continues to rotate into the chip manufacturing infrastructure layer.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is under intense focus as investors weigh its role as a strategic domestic supplier against recent geopolitical developments and concerns regarding potential supply chain shifts following diplomatic discussions between the U.S. and China. The community remains deeply divided, with some highlighting the company's long-term defense-linked contracts and national security importance as a solid foundation, while others express frustration over recent price volatility, insider selling, and the ongoing sector-wide struggle to reach consistent profitability.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which validates the company's solid-state battery technology and marks a significant expansion of its OEM partner ecosystem. Investors are actively discussing the implications of this partnership for commercialization, the potential for further OEM reveals, and the stock's long-term viability as the company transitions from R&D toward manufacturing at scale.

United Microelectronics Corp. is engaged in the semiconductor foundry company which provides IC fabrication services, focusing on logic and various technologies to serve all major sectors of the electronics industry. It offers complementary metal-oxide semiconductor logic wafers, mixed signal wafers, radio frequency complementary metal-oxide semiconductor wafers, embedded memory products, high voltage integrated circuits, and complementary metal-oxide semiconductor image sensors. The company was founded on May 22, 1980 and is headquartered in Hsinchu, Taiwan.

United Micro Electronics - ADR

United Microelectronics Corporation

United Microelectronics Corporation is trending as investors digest a series of positive technical breakouts and bullish sentiment regarding the company's long-term competitive positioning within the semiconductor foundry space. The community is actively discussing the firm's strategic focus on specialty technology nodes and the potential for a structural re-rating, with many focusing on its solid balance sheet and role as a key infrastructure provider in the AI-driven data center market.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing intense investor interest as the community prepares for a series of pivotal Phase 3 clinical data readouts expected throughout the summer. While discussions are polarized between optimism for potential breakthroughs in mental health treatment and concerns regarding cash burn and dilution, the stock remains a central focus as investors weigh the high-reward upside of these upcoming trials against standard biotech risks.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending due to surging interest in the AI infrastructure and 'Neocloud' sector, fueled by its role as an emerging proxy for Cerebras-linked compute capacity and upcoming earnings. The community is actively discussing the stock's thin float, high short interest, and its strategic partnership with Nscale, while speculating on the impact of the upcoming Cerebras IPO.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as the community highlights its strategic position as a critical, non-China-dependent supplier of rare earth elements for U.S. defense and commercial applications. Investors are actively discussing the stock's upcoming Russell 3000 index inclusion, recent supply off-take agreements, and the broader push for domestic critical mineral supply chain independence.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is attracting intense community speculation as investors closely monitor insider activity, significant institutional ownership, and ongoing patent developments. The conversation is largely driven by anticipation of upcoming clinical trial milestones and potential takeover interest, with the community actively debating the silence from leadership versus the strategic long-term accumulation of shares by management.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SBA Communications (SBAC) Down 7.5% Since Last Earnings Report: Can It Rebound?

SBA Communications (SBAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CUZ Q1 FFO Beats Estimates on Strong Leasing, Revenues Top

CUZ beats Q1 FFO estimates as leasing stays strong, revenues rise, and 2026 guidance widens with buybacks and debt financing gains.

Highwoods Properties Q1 Earnings Call Highlights

Highwoods Properties (NYSE:HIW) executives said the company posted what CEO Ted Klinck called an excellent quarter as leasing and development activity supported expectations for occupancy gains and...

HIW Q1 FFO Meets Estimates, Revenues Top on Rent Growth

HIW Q1 FFO matches estimates as revenues beat on rent growth. Leasing hits 958k sq ft, with 19.4% GAAP rent gains.

Highwoods Properties (HIW) Q1 FFO Meet Estimates

Highwoods Properties (HIW) delivered FFO and revenue surprises of +0.14% and +2.89%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Highwoods Properties (NYSE:HIW) Issues Quarterly Earnings Results, Beats Expectations By $0.71 EPS

Highwoods Properties (NYSE:HIW - Get Free Report) released its quarterly earnings results on Tuesday. The real estate investment trust reported $0.84 earnings per share for the quarter, topping the...

Highwoods Properties (NYSE:HIW) Updates FY 2026 Earnings Guidance

Highwoods Properties (NYSE:HIW) updated its FY 2026 earnings guidance. The company provided EPS guidance of 3.400-3.68 for the period, compared to the consensus estimate of 3.550...

Customers Bancorp (CUBI) Q1 Earnings and Revenues Surpass Estimates

Customers Bancorp (CUBI) delivered earnings and revenue surprises of +4.58% and +0.78%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Share Repurchase Program Declared by Highwoods Properties (NYSE:HIW) Board

Highwoods Properties (NYSE:HIW - Get Free Report) announced that its board has authorized a share repurchase plan on Wednesday, April 22nd, RTT News reports. The company plans to buyback $250.00...

Highwoods Properties, Inc. (NYSE:HIW) Receives Consensus Recommendation of "Hold" from Analysts

Highwoods Properties, Inc. (NYSE:HIW - Get Free Report) has received a consensus recommendation of "Hold" from the eight analysts that are currently covering the stock, Marketbeat reports. Six...

Highwoods Properties, Inc. is a real estate investment trust, which owns, develops, acquires, leases and manages properties. The firm also engages in the operation, acquisition, and development of rental office properties. It operates through the following geographical segments: Atlanta, Charlotte, Nashville, Orlando, Raleigh, Richmond, and Tampa. The company was founded by Ronald P. Gibson in 1994 and is headquartered in Raleigh, NC.

Highwoods Properties, Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.44	--	--	N/A
Q1 '26	$0.11	$0.29	169.71%	BEAT
Q4 '25	$0.20	$0.26	31.66%	BEAT
Q3 '25	$0.14	$0.12	-14.29%	MISSED
Q2 '25	$0.17	$0.17	2.00%	BEAT

HIWHighwoods Properties, Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest HIW News